Lanean...
Targeting Glucocorticoid Metabolism in Prostate Cancer
In the treatment of metastatic prostate cancer, resistance to hormonal therapy is a major obstacle. With antiandrogen therapies that suppress androgen signaling through the androgen receptor (AR), the primary driver of prostate cancer, some malignancies are able take advantage of the closely related...
Gorde:
| Argitaratua izan da: | Endocrinology |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8312637/ https://ncbi.nlm.nih.gov/pubmed/34180973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/endocr/bqab132 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|